| Neutrophil to lymphocyte ratio as a prognostic factor in European patients with epidermal growth factor receptor-mutant non-small cell lung cancer treated with tyrosine kinase … D Aguiar-Bujanda, A Dueñas-Comino, S Saura-Grau, L Ros-Sanjuan, ... Oncology Research and Treatment 41 (12), 755-761, 2018 | 22 | 2018 |
| Late-onset neutropenia after rituximab-containing therapy for non-Hodgkin lymphoma D Aguiar-Bujanda, MJ Blanco-Sánchez, M Hernández-Sosa, ... Clinical Lymphoma Myeloma and Leukemia 15 (12), 761-765, 2015 | 16 | 2015 |
| Treatment of gastric marginal zone B‐cell lymphoma of the mucosa‐associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone D Aguiar‐Bujanda, I Llorca‐Mártinez, JC Rivero‐Vera, ... Hematological Oncology 32 (3), 139-144, 2014 | 11 | 2014 |
| Critical appraisal of rituximab in the maintenance treatment of advanced follicular lymphoma D Aguiar-Bujanda, MJ Blanco-Sánchez, M Hernández-Sosa, ... Cancer management and research, 319-330, 2015 | 5 | 2015 |
| Therapeutic approaches in patients with newly diagnosed follicular lymphoma D Aguiar-Bujanda, MJ Blanco-Sánchez, P Jiménez-Gallego, ... Future Oncology 10 (12), 1967-1980, 2014 | 3 | 2014 |
| AXILLARY LYMPHADENECTOMY (AL) AFTER NEOADJUVANT CHEMOTHERAPY (NCT) IN PATIENTS WITH BREAST CANCER II-IIIB. OUR EXPERIENCE M Mori de Santiago, L Santiago Ojeda, I Reyes Rodriguez, ... INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 25 (9), 722-723, 2015 | | 2015 |
| Soft tissue sarcomas: A challenge for oncology. MJ Blanco Sanchez, S Hernandez Sarmiento, P Jimenez Gallego, ... Journal of Clinical Oncology 32 (15_suppl), e21512-e21512, 2014 | | 2014 |
| Tailored treatment with targeted therapies in non-small cell lung cancer (NSCLC) based on the epidermal growth factor receptor gene (EGFR) mutation testing. S Galvan Ruiz, M Hernandez Sosa, S Hernandez Sarmiento, ... Journal of Clinical Oncology 32 (15_suppl), e19150-e19150, 2014 | | 2014 |
